About OncoFlow

We're on a mission to transform cancer care through AI-powered decision support technology.

Our Story

OncoFlow uses AI to help healthcare professionals involved in cancer care create personalised management plans for cancer patients. This has the potential to reduce waiting times for cancer appointments, leading to earlier treatment which in turn significantly increases the chances of survival. Initially, OncoFlow will focus on breast cancer patients due to the high number of cases and waiting times. However, the platform can be adapted for other types of cancer in the future.

Our Team

Meet the dedicated professionals behind OncoFlow who are committed to transforming cancer care.

Maryam Hasanova

Chief Executive Officer

Maryam Hasanova is the Chief Executive Officer at OncoFlow, leading the company's vision and strategy to transform cancer care through AI-powered decision support technology.

Aruni Ghose

Co-Founder and Chief Medical Officer

Dr. Aruni Ghose is a Resident Doctor at the Barts Cancer Centre with extensive research focused on genitourinary, lung and breast oncology. With an H-index of 13 and over 50 peer-reviewed publications, he brings medical expertise and research excellence to OncoFlow's mission.